Convalescent Plasma Infusion to Decrease Coronavirus Associated Complications: An Open label, observational study of feasibility and safety of COVID-19 Convalescent plasma in hospitalized patients with severe and life-threatening COVID-19
The purpose of this study is to see if convalescent plasma will help treat COVID-19.
Participants will receive plasma from a person who has recovered from COVID-19. Researchers will collect information from participants' medical record as well as blood samples on days 1, 3, 7, 14, and 28.
- IRB Number: 2004139923
- Research Study Identifier: 2004139923
Recruitment StatusEnrolling By Invitation
If you need help finding a study or have any questions, please contact us at email@example.com or by phone at (888) 264-0005.